Table 2 Comparisons of the heart rate variability indices between survivors and non-survivors at 8-year follow-up.
Survivors (n = 85) | Non-survivors (n = 79) | p-value | |
|---|---|---|---|
Before the index hemodialysis session+ | |||
VLF-0 | 4.60 (3.77–5.51) | 4.14 (3.07–5.68) | 0.269 |
TP-0 | 5.28 (4.26–6.28) | 5.21 (4.12–6.37) | 0.813 |
Variance-0 | 5.54 (4.61–6.35) | 5.27 (4.16–6.55) | 0.676 |
nLF-0 | 41.40 (28.63–62.70) | 37.60 (19.30–51.40) | 0.177 |
nHF-0 | 31.55 (19.53–45.08) | 31.40 (21.05–38.43) | 0.417 |
LF/HF-0 | 0.20 (0.01–1.20) | 0.05 (0.01–0.81) | 0.472 |
Initial phase of the index hemodialysis session | |||
VLF-1 | 4.76 (4.12–5.98) | 5.24 (4.10–6.04) | 0.858 |
TP-1 | 5.58 (4.69–6.49) | 5.69 (4.53–6.60) | 0.973 |
Variance-1 | 5.71 (4.87–6.65) | 5.71 (4.55–6.73) | 0.954 |
nLF-1 | 47.20 (32.10–66.60) | 44.70 (26.30–61.70) | 0.338 |
nHF-1 | 30.30 (19.40–43.10) | 29.40 (21.30–41.90) | 0.908 |
LF/HF-1 | 0.41 (0.01–1.15) | 0.33 (0.01–0.99) | 0.671 |
Middle phase of the index hemodialysis session | |||
VLF-2 | 5.47 (4.29–6.22) | 5.29 (4.25–6.16) | 0.722 |
TP-2 | 5.86 (5.17–6.94) | 5.94 (4.80–7.28) | 0.991 |
Variance-2 | 5.99 (5.05–6.97) | 5.96 (4.98–7.31) | 0.794 |
nLF-2 | 48.40 (32.70–66.70) | 46.70 (30.50–60.20) | 0.448 |
nHF-2 | 28.00 (19.40–39.10) | 29.00 (19.20–36.50) | 0.982 |
LF/HF-2 | 0.47 (0.01–1.15) | 0.44 (0.01–1.04) | 0.901 |
Late phases of the index HD session+ | |||
VLF-3 | 5.33 (3.94–6.47) | 4.94 (3.96–6.17) | 0.522 |
TP-3 | 5.83 (4.79–7.19) | 5.67 (4.61–7.19) | 0.580 |
Variance-3 | 6.05 (4.92–7.08) | 5.75 (4.76–7.16) | 0.558 |
nLF-3 | 47.85 (31.05–67.90) | 44.65 (277.78–63.80) | 0.750 |
nHF-3 | 25.00 (18.88–38.43) | 28.00 (18.95–38.20) | 0.837 |
LF/HF-3 | 0.52 (0.01–1.25) | 0.50 (0.01–1.14) | 0.735 |
